01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
01. Gene therapy Boulikas.pdf - Gene therapy & Molecular Biology
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
protein (e.g. Smith et al, 1995; Fong et al, 1995; Shalaby<br />
et al, 1995).<br />
<strong>Gene</strong> transfer to the embryo has shown the importance<br />
of the promoter, large genomic regulatory regions, cellcell<br />
interactions and gene switch taking place during<br />
embryogenesis in maintaining transgene expression in<br />
different tissues; results obtained in embryos reflect the in<br />
vivo patterns of tissue-specific expression which could be<br />
useful to direct efforts in promoter choices for somatic<br />
gene transfer to the adult (as is the case for most gene<br />
<strong>therapy</strong> applications). Furthermore these studies provide<br />
the foundation of a new era where genetic manipulation of<br />
the embryo could permanently correct monogenic genetic<br />
disorders such as hemophilias, thalassemias and others.<br />
The promoter of the tie gene, which encodes a receptor<br />
tyrosine kinase that is expressed in the endothelium of<br />
blood vessels, was used to drive the expression of a<br />
luciferase reporter gene construct; in cultured cells the<br />
luciferase activity was not restricted to endothelial cells. In<br />
contrast, in transgenic mice expression of the reporter βgalactosidase<br />
was restricted to endothelial cells<br />
undergoing vasculogenesis and angiogenesis; in adult<br />
transgenic mice, tie promoter activity in lung and many<br />
vessels of the kidney was as high as in the vessels of the<br />
corresponding embryonic tissues, whereas in the heart,<br />
brain and liver, tie promoter activity was downregulated<br />
and restricted to coronaries, cusps, capillaries, and arteries<br />
(Korhonen et al, 1995).<br />
<strong>Gene</strong> Therapy and <strong>Molecular</strong> <strong>Biology</strong> Vol 1, page 85<br />
85<br />
A retroviral VEGF expression vector was used to<br />
infect quail ebryo and to increase the level of VEGF<br />
during critical periods of avian limb bud growth and<br />
morphogenesis. Overexpression of VEGF in the limb bud<br />
exclusively resulted in hypervascularization as reflected<br />
by an increase in vascular density from an augmentation<br />
of the VEGF signaling mechanism in a permissive<br />
environment; vascular permeability was also dramatically<br />
increased leading to local edema (Flamme et al, 1995).<br />
An avian leukosis virus (ALV)-based retroviral vector<br />
system was used for the efficient delivery of genes into<br />
preimplantation mouse embryos; a subset of the integrated<br />
proviruses expressed the delivered chloramphenicol<br />
acetyltransferase (CAT) reporter gene either from the<br />
constitutive viral promoter contained in the long terminal<br />
repeat or from the internal nonviral tissue-specific<br />
promoter in different sets of experiments. Thus, many of<br />
the sites that are accessible to viral DNA insertion in<br />
preimplantation embryos were thought to be incompatible<br />
with expression in older animals (Federspiel et al, 1996).<br />
Baldwin and coworkers (1997) have found that the<br />
expression of lacZ gene under control of CMV or RSV<br />
promoter transferred to early, postgastrulation mouse<br />
embryos gave tissue-specific patterns of expression which<br />
depended on the type of promoter used. Embryos were<br />
injected into the mesoderm of the neural fold (A in Figure<br />
30) and β-galactosidase activity was detected in the head